SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-149377
Filing Date
2023-05-19
Accepted
2023-05-19 16:31:04
Documents
16
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d403468ddef14a.htm DEF 14A 323922
2 GRAPHIC g403468dsp36a.jpg GRAPHIC 12922
3 GRAPHIC g403468dsp36b.jpg GRAPHIC 6674
4 GRAPHIC g403468dsp36c.jpg GRAPHIC 2796
5 GRAPHIC g403468dsp36d.jpg GRAPHIC 1388
6 GRAPHIC g403468dsp36e.jpg GRAPHIC 2607
7 GRAPHIC g403468dsp36f.jpg GRAPHIC 1054
8 GRAPHIC g403468dsp36g.jpg GRAPHIC 1517
9 GRAPHIC g403468dsp36h.jpg GRAPHIC 1065
10 GRAPHIC g403468dsp36i.jpg GRAPHIC 8939
11 GRAPHIC g403468dsp36j.jpg GRAPHIC 805
12 GRAPHIC g403468dsp36k.jpg GRAPHIC 6962
13 GRAPHIC g403468dsp37a.jpg GRAPHIC 1504
14 GRAPHIC g403468dsp37b.jpg GRAPHIC 1520
15 GRAPHIC g403468dsp37c.jpg GRAPHIC 763
16 GRAPHIC g403468g68p04.jpg GRAPHIC 63831
  Complete submission text file 0001193125-23-149377.txt   484243
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41583 | Film No.: 23940725
SIC: 2834 Pharmaceutical Preparations